Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Ligand Pharmaceuticals (LGND) over the last 16 years, with Q3 2025 value amounting to -$148000.0.

  • Ligand Pharmaceuticals' Other Working Capital Changes rose 9815.21% to -$148000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year increase of 7708.75%. This contributed to the annual value of $7.7 million for FY2024, which is 2171.31% down from last year.
  • As of Q3 2025, Ligand Pharmaceuticals' Other Working Capital Changes stood at -$148000.0, which was up 9815.21% from $4.3 million recorded in Q2 2025.
  • In the past 5 years, Ligand Pharmaceuticals' Other Working Capital Changes registered a high of $9.6 million during Q4 2023, and its lowest value of -$8.9 million during Q2 2021.
  • Its 5-year average for Other Working Capital Changes is -$27631.6, with a median of $73000.0 in 2023.
  • Per our database at Business Quant, Ligand Pharmaceuticals' Other Working Capital Changes soared by 93094.83% in 2023 and then crashed by 1107123.29% in 2024.
  • Over the past 5 years, Ligand Pharmaceuticals' Other Working Capital Changes (Quarter) stood at $2.8 million in 2021, then plummeted by 141.05% to -$1.2 million in 2022, then surged by 930.95% to $9.6 million in 2023, then decreased by 7.72% to $8.9 million in 2024, then plummeted by 101.66% to -$148000.0 in 2025.
  • Its Other Working Capital Changes stands at -$148000.0 for Q3 2025, versus $4.3 million for Q2 2025 and $2.0 million for Q1 2025.